ESR2 and multiple sclerosis: In this study, we demonstrate that small-molecule chloroindazole ERβ ligands, optimized for selective ERβ engagement and favorable pharmaceutical and pharmacokinetic profiles suitable for oral administration, exert multiple therapeutic effects in mouse models of multiple sclerosis (Fig. 9).